Global ED Treatment Market Research Report 2023

Report ID: 2009631 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 ED Treatment Market Overview
    1.1 Product Overview and Scope of ED Treatment
    1.2 ED Treatment Segment by Type
        1.2.1 Global ED Treatment Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Sildenafil
        1.2.3 Tadalafil
        1.2.4 Others
    1.3 ED Treatment Segment by Application
        1.3.1 Global ED Treatment Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Drugstores
        1.3.4 Other
    1.4 Global ED Treatment Market Size Estimates and Forecasts
        1.4.1 Global ED Treatment Revenue 2017-2028
        1.4.2 Global ED Treatment Sales 2017-2028
        1.4.3 ED Treatment Market Size by Region: 2017 Versus 2021 Versus 2028
2 ED Treatment Market Competition by Manufacturers
    2.1 Global ED Treatment Sales Market Share by Manufacturers (2017-2022)
    2.2 Global ED Treatment Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global ED Treatment Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers ED Treatment Manufacturing Sites, Area Served, Product Type
    2.5 ED Treatment Market Competitive Situation and Trends
        2.5.1 ED Treatment Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest ED Treatment Players Market Share by Revenue
        2.5.3 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ED Treatment Retrospective Market Scenario by Region
    3.1 Global ED Treatment Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global ED Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America ED Treatment Market Facts & Figures by Country
        3.3.1 North America ED Treatment Sales by Country
        3.3.2 North America ED Treatment Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe ED Treatment Market Facts & Figures by Country
        3.4.1 Europe ED Treatment Sales by Country
        3.4.2 Europe ED Treatment Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific ED Treatment Market Facts & Figures by Region
        3.5.1 Asia Pacific ED Treatment Sales by Region
        3.5.2 Asia Pacific ED Treatment Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America ED Treatment Market Facts & Figures by Country
        3.6.1 Latin America ED Treatment Sales by Country
        3.6.2 Latin America ED Treatment Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa ED Treatment Market Facts & Figures by Country
        3.7.1 Middle East and Africa ED Treatment Sales by Country
        3.7.2 Middle East and Africa ED Treatment Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global ED Treatment Historic Market Analysis by Type
    4.1 Global ED Treatment Sales Market Share by Type (2017-2022)
    4.2 Global ED Treatment Revenue Market Share by Type (2017-2022)
    4.3 Global ED Treatment Price by Type (2017-2022)
5 Global ED Treatment Historic Market Analysis by Application
    5.1 Global ED Treatment Sales Market Share by Application (2017-2022)
    5.2 Global ED Treatment Revenue Market Share by Application (2017-2022)
    5.3 Global ED Treatment Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Eli Lilly
        6.1.1 Eli Lilly Corporation Information
        6.1.2 Eli Lilly Description and Business Overview
        6.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Eli Lilly ED Treatment Product Portfolio
        6.1.5 Eli Lilly Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Pfizer ED Treatment Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Bayer
        6.3.1 Bayer Corporation Information
        6.3.2 Bayer Description and Business Overview
        6.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Bayer ED Treatment Product Portfolio
        6.3.5 Bayer Recent Developments/Updates
    6.4 BaiYunShan General Factory
        6.4.1 BaiYunShan General Factory Corporation Information
        6.4.2 BaiYunShan General Factory Description and Business Overview
        6.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 BaiYunShan General Factory ED Treatment Product Portfolio
        6.4.5 BaiYunShan General Factory Recent Developments/Updates
    6.5 S.K. Chemicals
        6.5.1 S.K. Chemicals Corporation Information
        6.5.2 S.K. Chemicals Description and Business Overview
        6.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 S.K. Chemicals ED Treatment Product Portfolio
        6.5.5 S.K. Chemicals Recent Developments/Updates
    6.6 Teva Pharma
        6.6.1 Teva Pharma Corporation Information
        6.6.2 Teva Pharma Description and Business Overview
        6.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Teva Pharma ED Treatment Product Portfolio
        6.6.5 Teva Pharma Recent Developments/Updates
    6.7 Dong-A ST
        6.6.1 Dong-A ST Corporation Information
        6.6.2 Dong-A ST Description and Business Overview
        6.6.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Dong-A ST ED Treatment Product Portfolio
        6.7.5 Dong-A ST Recent Developments/Updates
    6.8 Metuchen Pharma
        6.8.1 Metuchen Pharma Corporation Information
        6.8.2 Metuchen Pharma Description and Business Overview
        6.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Metuchen Pharma ED Treatment Product Portfolio
        6.8.5 Metuchen Pharma Recent Developments/Updates
    6.9 Seoul Pharma
        6.9.1 Seoul Pharma Corporation Information
        6.9.2 Seoul Pharma Description and Business Overview
        6.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Seoul Pharma ED Treatment Product Portfolio
        6.9.5 Seoul Pharma Recent Developments/Updates
    6.10 CSBIO.
        6.10.1 CSBIO. Corporation Information
        6.10.2 CSBIO. Description and Business Overview
        6.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 CSBIO. ED Treatment Product Portfolio
        6.10.5 CSBIO. Recent Developments/Updates
7 ED Treatment Manufacturing Cost Analysis
    7.1 ED Treatment Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of ED Treatment
    7.4 ED Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 ED Treatment Distributors List
    8.3 ED Treatment Customers
9 ED Treatment Market Dynamics
    9.1 ED Treatment Industry Trends
    9.2 ED Treatment Market Drivers
    9.3 ED Treatment Market Challenges
    9.4 ED Treatment Market Restraints
10 Global Market Forecast
    10.1 ED Treatment Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of ED Treatment by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of ED Treatment by Type (2023-2028)
    10.2 ED Treatment Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of ED Treatment by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of ED Treatment by Application (2023-2028)
    10.3 ED Treatment Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of ED Treatment by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of ED Treatment by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global ED Treatment Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global ED Treatment Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global ED Treatment Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global ED Treatment Market Competitive Situation by Manufacturers in 2021
    Table 5. Global ED Treatment Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global ED Treatment Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global ED Treatment Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global ED Treatment Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market ED Treatment Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers ED Treatment Manufacturing Sites and Area Served
    Table 11. Manufacturers ED Treatment Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global ED Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ED Treatment as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global ED Treatment Sales by Region (2017-2022) & (K Units)
    Table 16. Global ED Treatment Sales Market Share by Region (2017-2022)
    Table 17. Global ED Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global ED Treatment Revenue Market Share by Region (2017-2022)
    Table 19. North America ED Treatment Sales by Country (2017-2022) & (K Units)
    Table 20. North America ED Treatment Sales Market Share by Country (2017-2022)
    Table 21. North America ED Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America ED Treatment Revenue Market Share by Country (2017-2022)
    Table 23. Europe ED Treatment Sales by Country (2017-2022) & (K Units)
    Table 24. Europe ED Treatment Sales Market Share by Country (2017-2022)
    Table 25. Europe ED Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe ED Treatment Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific ED Treatment Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific ED Treatment Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific ED Treatment Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific ED Treatment Revenue Market Share by Region (2017-2022)
    Table 31. Latin America ED Treatment Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America ED Treatment Sales Market Share by Country (2017-2022)
    Table 33. Latin America ED Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America ED Treatment Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa ED Treatment Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa ED Treatment Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa ED Treatment Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa ED Treatment Revenue Market Share by Country (2017-2022)
    Table 39. Global ED Treatment Sales by Type (2017-2022) & (K Units)
    Table 40. Global ED Treatment Sales Market Share by Type (2017-2022)
    Table 41. Global ED Treatment Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global ED Treatment Revenue Share by Type (2017-2022)
    Table 43. Global ED Treatment Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global ED Treatment Sales (K Units) by Application (2017-2022)
    Table 45. Global ED Treatment Sales Market Share by Application (2017-2022)
    Table 46. Global ED Treatment Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global ED Treatment Revenue Share by Application (2017-2022)
    Table 48. Global ED Treatment Price by Application (2017-2022) & (USD/Unit)
    Table 49. Eli Lilly Corporation Information
    Table 50. Eli Lilly Description and Business Overview
    Table 51. Eli Lilly ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Eli Lilly ED Treatment Product
    Table 53. Eli Lilly Recent Developments/Updates
    Table 54. Pfizer Corporation Information
    Table 55. Pfizer Description and Business Overview
    Table 56. Pfizer ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Pfizer ED Treatment Product
    Table 58. Pfizer Recent Developments/Updates
    Table 59. Bayer Corporation Information
    Table 60. Bayer Description and Business Overview
    Table 61. Bayer ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Bayer ED Treatment Product
    Table 63. Bayer Recent Developments/Updates
    Table 64. BaiYunShan General Factory Corporation Information
    Table 65. BaiYunShan General Factory Description and Business Overview
    Table 66. BaiYunShan General Factory ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. BaiYunShan General Factory ED Treatment Product
    Table 68. BaiYunShan General Factory Recent Developments/Updates
    Table 69. S.K. Chemicals Corporation Information
    Table 70. S.K. Chemicals Description and Business Overview
    Table 71. S.K. Chemicals ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. S.K. Chemicals ED Treatment Product
    Table 73. S.K. Chemicals Recent Developments/Updates
    Table 74. Teva Pharma Corporation Information
    Table 75. Teva Pharma Description and Business Overview
    Table 76. Teva Pharma ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Teva Pharma ED Treatment Product
    Table 78. Teva Pharma Recent Developments/Updates
    Table 79. Dong-A ST Corporation Information
    Table 80. Dong-A ST Description and Business Overview
    Table 81. Dong-A ST ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Dong-A ST ED Treatment Product
    Table 83. Dong-A ST Recent Developments/Updates
    Table 84. Metuchen Pharma Corporation Information
    Table 85. Metuchen Pharma Description and Business Overview
    Table 86. Metuchen Pharma ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Metuchen Pharma ED Treatment Product
    Table 88. Metuchen Pharma Recent Developments/Updates
    Table 89. Seoul Pharma Corporation Information
    Table 90. Seoul Pharma Description and Business Overview
    Table 91. Seoul Pharma ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Seoul Pharma ED Treatment Product
    Table 93. Seoul Pharma Recent Developments/Updates
    Table 94. CSBIO. Corporation Information
    Table 95. CSBIO. Description and Business Overview
    Table 96. CSBIO. ED Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. CSBIO. ED Treatment Product
    Table 98. CSBIO. Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. ED Treatment Distributors List
    Table 102. ED Treatment Customers List
    Table 103. ED Treatment Market Trends
    Table 104. ED Treatment Market Drivers
    Table 105. ED Treatment Market Challenges
    Table 106. ED Treatment Market Restraints
    Table 107. Global ED Treatment Sales Forecast by Type (2023-2028) & (K Units)
    Table 108. Global ED Treatment Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global ED Treatment Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global ED Treatment Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global ED Treatment Sales Forecast by Application (2023-2028) & (K Units)
    Table 112. Global ED Treatment Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global ED Treatment Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global ED Treatment Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global ED Treatment Sales Forecast by Region (2023-2028) & (K Units)
    Table 116. Global ED Treatment Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global ED Treatment Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global ED Treatment Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of ED Treatment
    Figure 2. Global ED Treatment Market Share by Type in 2021 & 2028
    Figure 3. Sildenafil Product Picture
    Figure 4. Tadalafil Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global ED Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Drugstores
    Figure 9. Other
    Figure 10. Global ED Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global ED Treatment Market Size (2017-2028) & (US$ Million)
    Figure 12. Global ED Treatment Sales (2017-2028) & (K Units)
    Figure 13. ED Treatment Sales Share by Manufacturers in 2021
    Figure 14. Global ED Treatment Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest ED Treatment Players: Market Share by Revenue in 2021
    Figure 16. ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global ED Treatment Sales Market Share by Region (2017-2022)
    Figure 18. Global ED Treatment Sales Market Share by Region in 2021
    Figure 19. Global ED Treatment Revenue Market Share by Region (2017-2022)
    Figure 20. Global ED Treatment Revenue Market Share by Region in 2021
    Figure 21. U.S. ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Taiwan ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Philippines ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Vietnam ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. U.A.E ED Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of ED Treatment by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of ED Treatment
    Figure 47. Manufacturing Process Analysis of ED Treatment
    Figure 48. ED Treatment Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Frequently Asked Questions
ED Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
ED Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
ED Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports